SCHEMBL2009244

SCHEMBL2009244

O=Cc1cnnc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.44
LMNA P02545 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ERN1 O75460 2/20 0.41
TGFBR1 P36897 1/20 0.37
CYP2A6 P11509 2/20 0.37
IMPDH2 P12268 2/20 0.37
KDM4E B2RXH2 2/20 0.36
NPC1 O15118 2/20 0.36
HSP90AA1 P07900 1/20 0.36
IDO1 P14902 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13134221 0.80 GPR3 (0.44) GPR3LMNAMEN1KMT2ABLM
SCHEMBL9114832 0.80 GPR3 (0.44) GPR3LMNAMEN1KMT2ATGFBR1
SCHEMBL10738301 0.76 HPGD (0.42) GPR3LMNAMEN1KMT2ATGFBR1
SCHEMBL10738298 0.76 HPGD (0.42) GPR3LMNAMEN1KMT2ATGFBR1
SCHEMBL2491042 0.76 MAPT (0.44) GPR3LMNAMEN1KMT2AKDM4E
SCHEMBL2491044 0.76 MAPT (0.44) GPR3LMNAMEN1KMT2AKDM4E
SCHEMBL2008924 0.74 KMT2A (0.39) GPR3LMNAMEN1KMT2ATHRB
Hydrochloric Acid SCHEMBL10842837 0.74 HPGD (0.41) GPR3LMNAMEN1KMT2ATGFBR1
SCHEMBL9111565 0.74 GPR3 (0.39) GPR3LMNAMEN1KMT2ATGFBR1
SCHEMBL276531 0.72 GPR3 (0.50) GPR3LMNAMEN1KMT2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105246893-B It is used as the pyrazolo benzodiazine derovatives of METAP2 (2 type methionine aminopeptidase) inhibitor 赛诺菲 2017-10-27 CN claimed
CN-103687852-B 2-amino-3-(imidazoles-2-base)-pyridin-4-one derivatives and the purposes as vegf receptor kinase inhibitor thereof 赛诺菲 2016-08-17 CN claimed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20190071407-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES SYNGENTA CROP PROTECTION LLC (US) 2019-03-07 US disclosed
US-10155730-B2 Isoxazoline derivatives as insecticides SYNGENTA CROP PROTECTION, LLC (US) 2018-12-18 US disclosed
CN-105377849-B For preventing and kill off the substituted pyrimidines * compounds and derivative of animal pest 巴斯夫欧洲公司 2018-01-26 CN disclosed
CN-105246893-B It is used as the pyrazolo benzodiazine derovatives of METAP2 (2 type methionine aminopeptidase) inhibitor 赛诺菲 2017-10-27 CN disclosed
CN-104602691-B VEGFR 3 inhibitor is for treating the purposes of hepatocarcinoma 赛诺菲 2016-12-28 CN disclosed
US-20160368883-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES SYNGENTA CROP PROTECTION LLC (US) 2016-12-22 US disclosed
CN-103687852-B 2-amino-3-(imidazoles-2-base)-pyridin-4-one derivatives and the purposes as vegf receptor kinase inhibitor thereof 赛诺菲 2016-08-17 CN disclosed
CN-105377849-A Substituted pyrimidinium compounds and derivatives for combating animal pests BASF SE 2016-03-02 CN disclosed
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-03 US disclosed
CN-1889947-A Tetrahydronaphthalene derivatives, process for their preparation and their use as anti-inflammatory agents SCHERING AG (DE) 2007-01-03 CN disclosed
EP-1732929-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS Nissan Chemical Industries, Ltd. (JP) 2006-12-20 EP disclosed
WO-2005090357-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-29 WO disclosed
CN-1158281-C 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor ��һ��������ҩ��ʽ���� 2004-07-21 CN disclosed
CN-1474689-A CDC25 phosphatase inhibitors ��ѧ�о���Ӧ����ѯ��˾ 2004-02-11 CN disclosed
US-6043226-A TREATING BACTERIAL, PARASITIC AND PROTOZOAL INFECTIONS PFIZER INC. (US) 2000-03-28 US disclosed
CN-1239478-A 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor SUNTORY LTD (JP) 1999-12-22 CN disclosed
CN-1014060-B METHOD FOR PREPARAING ORTHO-AZONAPHTHALENE COMPOUND IMP CHEMICAL IND PAN AMERICAL (US) 1991-09-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190071407-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES ACHE, CHRM1, ITPR3 GPR3 1178/4885LMNA 1648/4885MEN1 2329/4885
US-10155730-B2 Isoxazoline derivatives as insecticides ACHE, CHRM1, ITPR3 GPR3 1178/4885LMNA 1648/4885MEN1 2329/4885
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents CBR1, CBR3, SCN8A GPR3 759/4885LMNA 2770/4885MEN1 4065/4885
US-20160368883-A1 ISOXAZOLINE DERIVATIVES AS INSECTICIDES ACHE, CHRM1, ITPR3 GPR3 1178/4885LMNA 1648/4885MEN1 2329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.